TotalMarketCap

Precision Biosciences

DTILNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$274.748 M

$9.84 +21.12%

Close of 6 Nov 2026

As of 6 Nov 2026, Precision Biosciences (DTIL) has a market capitalization of $274.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$34.3M

#2828 by revenue

Earnings

-$45.7M

Loss-making

Shares outstanding

27,935,719

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #85Kyverna TherapeuticsKYTX$284.8M
  2. #86OcugenOCGN$276.5M
  3. #87Precision BiosciencesDTIL$274.7M
  4. #88Century TherapeuticsIPSC$273.4M
  5. #89SAB BiotherapeuticsSABS$266.6M

What if Precision Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,010,780

Per share 102,774× higher

Bitcoin $1.53T

$54,691.56

Per share 5,561× higher

Apple $5.02T

$179,547.29

Per share 18,256× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Precision Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.